N-tert-butyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide → N-acetyl-N'-tert-butyl-5-formyl-6-methoxy-biphenyl-3,3'-disulfonamide

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	N-tert-butyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide	HCID 58169119	—
Edukt	N-acetyl-5-bromo-3-formyl-4-methoxybenzenesulfonamide	HCID 86607697	—
Produkt	N-acetyl-N'-tert-butyl-5-formyl-6-methoxy-biphenyl-3,3'-disulfonamide	HCID 86607706	51,6%

Reaktionsschritte

Proceeding as in Reference 19, but substituting N-acetyl-3-bromo-5-formyl-4-methoxy-benzenesulfonamide (335 mg, 1.0 mmol) and N-tert-butyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzenesulfonamide (373 mg, 1.1 mmol), gave N-acetyl-N′-tert-butyl-5-formyl-6-methoxy-biphenyl-3,3′-disulfonamide (242 mg) as a pale yellow oil.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US09162986B2
Quelldatensatz	uspto-grants-2015_10
ORD ID	ord-4d95b28d43a64787a2a1aca2edbaadee
Quellennotiz	uspto-grants-2015_10